Ze-Yu Zhu

Ze-Yu Zhu

Auto-generated profile, based on publicly available information

Ze-Yu Zhu

Department of Neurology, Rui Jin Hospital & Rui Jin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
SRSebastian N. Roemer-Cassiano
Sebastian N. Roemer-Cassiano
FWFabian Wagner
Fabian Wagner
LELisa Evangelista
Lisa Evangelista
BRBoris-Stephan Rauchmann
Boris-Stephan Rauchmann
ADAmir Dehsarvi
Amir Dehsarvi
NFNicolai Franzmeier
Nicolai Franzmeier
In Alzheimer’s disease (AD), amyloid-β (Aβ) triggers the aggregation and spreading of tau pathology, which drives neurodegeneration and cognitive decline. However, the pathophysiological link between Aβ and tau remains unclear, which hinders therapeutic efforts to attenuate Aβ-related tau accumulation. Aβ has been found to trigger neuronal hyperactivity and hyperconnectivity, and preclinical research has shown that tau spreads across connected neurons in an activity-dependent manner. Here, we hypothesized that neuronal hyperactivity and hypersynchronicity, resulting in functional connectivity increases, constitute a crucial mechanism by which Aβ facilitates the spreading of tau pathology. By combining Aβ positron emission tomography (PET), resting-state functional magnetic resonance imaging, and longitudinal tau-PET in 69 cognitively normal amyloid-negative controls and 140 amyloid-positive patients covering the AD spectrum, we confirmed that Aβ induces hyperconnectivity of temporal lobe tau epicenters to posterior brain regions that are vulnerable to tau accumulation in AD. This was replicated in an independent sample of 55 controls and 345 individuals with preclinical AD and low cortical tau-PET uptake, suggesting that the emergence of Aβ-related hyperconnectivity precedes neocortical tau spreading . Last, using longitudinal tau-PET and mediation analysis, we confirmed that these Aβ-related connectivity increases in tau epicenters to typical tau-vulnerable brain regions in AD mediated the effect of Aβ on faster tau accumulation, unveiling increased connectivity as a potential causal link between the two AD hallmark pathologies. Together, these findings suggest that Aβ promotes tau spreading by eliciting neuronal hyperconnectivity and that targeting Aβ-related neuronal hyperconnectivity may attenuate tau spreading in AD.

2 December 2019 in Translational Neurodegeneration
Verified
Journal Article
Open access
PDF file
WTWotu Tian
Wotu Tian
FZFei-Xia Zhan
Fei-Xia Zhan
QLQing Liu
Qing Liu
XLXinghua Luan
Xinghua Luan
CZChao Zhang
Chao Zhang
LCli cao
li cao
Background: CSF1R-related leukoencephalopathy, also known as hereditary diffuse leukoencephalopathy with spheroids (HDLS), is a rare white-matter encephalopathy characterized by motor and neuropsychiatric symptoms due to colony-stimulating factor 1 receptor (CSF1R) gene mutation. Few of CSF1R mutations have been functionally testified and the pathogenesis remains unknown. Methods: In order to investigate clinical and pathological characteristics of patients with CSF1R-related leukoencephalopathy and explore the potential impact of CSF1R mutations, we analyzed clinical manifestations of 15 patients from 10 unrelated families and performed brain biopsy in 2 cases. Next generation sequencing was conducted for 10 probands to confirm the diagnosis. Sanger sequencing, segregation analysis and phenotypic reevaluation were utilized to substantiate findings. Functional examination of identified mutations was further explored. Results: Clinical and neuroimaging characteristics were summarized. The average age at onset was 35.9 ± 6.4 years (range 24–46 years old). Younger age of onset was observed in female than male (34.2 vs. 39.2 years). The most common initial symptoms were speech dysfunction, cognitive decline and parkinsonian symptoms. One patient also had marked peripheral neuropathy. Brain biopsy of two cases showed typical pathological changes, including myelin loss, axonal spheroids, phosphorylated neurofilament and activated macrophages. Electron microscopy disclosed increased mitochondrial vacuolation and disorganized neurofilaments in ballooned axons. A total of 7 pathogenic variants (4 novel, 3 documented) were identified with autophosphorylation deficiency, among which c.2342C > T remained partial function of autophosphorylation. Western blotting disclosed the significantly lower level of c.2026C > T (p.R676*) than wild type. The level of microtubule associated protein 1 light chain 3-II (LC3-II), a classical marker of autophagy, was significantly lower in mutants expressed cells than wild type group by western blotting and immunofluorescence staining. Conclusions: Our findings support the loss-of-function and haploinsufficiency hypothesis in pathogenesis. Autophagy abnormality may play a role in the disease. Repairing or promoting the phosphorylation level of mutant CSF1R may shed light on therapeutic targets in the future. However, whether peripheral polyneuropathy potentially belongs to CSF1R-related spectrum deserves further study with longer follow-up and more patients enrolled. Trial registration: ChiCTR, ChiCTR1800015295. Registered 21 March 2018.

15 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
XSXiaoxuan Song
Xiaoxuan Song
ZZZeyu Zhu
Zeyu Zhu
XQXiaohang Qian
Xiaohang Qian
XLXiaoli Liu
Xiaoli Liu
Sheng ChenSheng Chen
Sheng Chen
SCSheng-Di Chen
Sheng-Di Chen
Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder frequently accompanied by cognitive impairment. Contributing factors such as modern lifestyle, genetic predisposition, and gene environmental interactions have been postulated, but the pathogenesis remains unclear. In this study, we attempt to investigate the potential mechanisms and interventions underlying T2DM-induced cognitive deficits from the brain–gut axis perspective. A combined analysis of the brain transcriptome, plasma metabolome, and gut microbiota in db/db mice with cognitive decline was conducted. Transcriptome analysis identified 222 upregulated gene sets and 85 downregulated gene sets, mainly related to mitochondrial respiratory, glycolytic, and inflammation. In metabolomic analysis, a total of 75 significantly altered metabolites were identified, correlated with disturbances of glucose, lipid, bile acid, and steroid metabolism under disease state. Gut microbiota analysis suggested that the species abundance and diversity of db/db mice were significantly increased, with 23 significantly altered genus detected. Using the multi-omics integration, significant correlations among key genes (n = 33), metabolites (n = 41), and bacterial genera (n = 21) were identified. Our findings suggest that disturbed circulation and brain energy metabolism, especially mitochondrial-related disturbances, may contribute to cognitive impairment in db/db mice. This study provides novel insights into the functional interactions among the brain, circulating metabolites, and gut microbiota.

1 January 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
XQXiao-Hang Qian
Xiao-Hang Qian
XLXiao-Ying Liu
Xiao-Ying Liu
ZZZe-Yu Zhu
Ze-Yu Zhu
SWShi-Ge Wang
Shi-Ge Wang
XSXiao-Xuan Song
Xiao-Xuan Song
LCli cao
li cao

1 January 2020 in Neuroscience Letters
Verified
Journal Article
Closed access
FZFei-Xia Zhan
Fei-Xia Zhan
WTWotu Tian
Wotu Tian
CZChao Zhang
Chao Zhang
ZZZe-Yu Zhu
Ze-Yu Zhu
SWShi-Ge Wang
Shi-Ge Wang
LCli cao
li cao

1 December 2019 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
ZZZeyu Zhu
Zeyu Zhu
CZChao Zhang
Chao Zhang
GZGuohua Zhao
Guohua Zhao
QLQing Liu
Qing Liu
PZPing Zhong
Ping Zhong
LCli cao
li cao